2023
DOI: 10.1002/jlcr.4023
|View full text |Cite
|
Sign up to set email alerts
|

Peptides for trans‐blood–brain barrier delivery

Abstract: Trans‐blood–brain barrier (BBB) delivery of therapeutic and diagnostic agents is a major challenge in the development of central nervous system (CNS) targeted radiopharmaceuticals. This review is an introduction to the use of peptides as delivery agents to transport cargos into the CNS. The most widely used BBB‐penetrating peptides are reviewed here, with a particular emphasis on the broad range of cargos delivered into the CNS using these. Cell‐penetrating peptides (CPPs) have been deployed as trans‐BBB deliv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 153 publications
(285 reference statements)
0
2
0
Order By: Relevance
“…The moderate BBB penetration capability of MB-CPDs demonstrated their potential for in vivo therapeutic applications. A further increase of the BBB penetration capability of MB-CPDs could be achieved by coupling a cell-penetrating peptide. , …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The moderate BBB penetration capability of MB-CPDs demonstrated their potential for in vivo therapeutic applications. A further increase of the BBB penetration capability of MB-CPDs could be achieved by coupling a cell-penetrating peptide. , …”
Section: Resultsmentioning
confidence: 99%
“…A further increase of the BBB penetration capability of MB-CPDs could be achieved by coupling a cell-penetrating peptide. 66,67…”
Section: Resultsmentioning
confidence: 99%